4th Quarter - Report

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
$50,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Rare disease initiatives. Newborn Screening. Genetic Testing Access. Medical Nutrition. Affordable Care Act (ACA) Issues and Enhancements.

LobbyistCovered position, as disclosed
CORINNE ALBERTS —
ALLISON HERRITY New —
HEIDI ROSS —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Medicare/Medicaid MMM

Medicare / Medicaid issues impacting patients with rare diseases. H.R.3089/S.1544: Accelerating Kids Access to Care Act. Inflation Reduction Act Implementation.

LobbyistCovered position, as disclosed
CORINNE ALBERTS —
KARIN HOELZER —
HEIDI ROSS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3089 (117th), S. 1544 (117th)

Pharmacy PHA

Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Rare Disease Trial Design. Prescription Drug User Fee Act (PDUFA) Reauthorization. User Fee Agreements. Inflation Reduction Act Implementation. NIH Translation Science Issues.

LobbyistCovered position, as disclosed
KARIN HOELZER New —
HEIDI ROSS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.